Diabetic transgenic mice harboring CaMKII oxidant-resistant mutations MM-VV were protected against myocardial infarction, exhibiting reduced pace-maker cell apoptosis, heart rate, and disease associated mortality (Luo et al., 2013). Here, CAMK2G is linked to myocardial infarction.